(36) observed a 7-fold reduction in tumor burden in Tsc2+/- mice treated with N-ethyl-N-nitrosourea to increase the incidence and severity of renal lesions after treating with 10 mg/kg everolimus PO QD (5/7 days per week). Here, TSC2 is linked to neoplasm.